Fingolimod data
Response to a request for data on fingolimod and other medicines.
26 November 2019
[name and contact details redacted]
Dear [name redacted]
REQUEST FOR INFORMATION
Thank you for your request dated 2 November 2019 under the Official Information Act 1982 (OIA) for information on drug usage. You asked for
the usage (in both retail and hospital pharmacy channels) of the drugs below in the past three years:
- Fingolimod 0.5mg capsules
- Levodopa+Benserazide tablets 100mg + 25mg
- Levodopa+Benserazide tablets 200 mg + 50mg
PHARMAC does not collect information on drug usage, data is only collected for medicines dispensed. We have provided this information in the table below.
|
Chemical and presentation |
Year |
Number of units dispensed in community |
Number of units purchased by hospitals |
Total |
|
Fingolimod Cap 0.5 mg |
2016 |
61,553 |
336 |
61,889 |
|
2017 |
134,781 |
308 |
135,089 |
|
|
2018 |
142,647 |
167 |
142,814 |
|
|
2019 |
71,179 |
225 |
71,404 |
|
|
Levodopa with benserazide, Cap 200 mg with benserazide 50 mg |
2016 |
100,869 |
2,600 |
103,469 |
|
2017 |
206,084 |
3,196 |
209,280 |
|
|
2018 |
222,008 |
4,716 |
226,724 |
|
|
2019 |
110,834 |
2,176 |
113,010 |
|
|
Levodopa with benserazide, Cap 100 mg with benserazide 25 mg |
2016 |
681,596 |
13,500 |
695,096 |
|
2017 |
1,433,526 |
24,444 |
1,457,970 |
|
|
2018 |
1,575,855 |
21,008 |
1,596,863 |
|
|
2019 |
844,035 |
13,432 |
857,467 |
We trust that this information answers your queries. We are making our information more freely available, so we will now publish selected OIA responses (excluding personal details) on our website. Please get in touch with us if you have any questions about this.
Yours sincerely
Alison Hill
Director, Engagement and Implementation